ArticleJournal of immunology (Baltimore, Md. : 1950)2025

Novel RORγt inverse agonists limit IL-17-mediated liver inflammation and fibrosis.

Afrooz Dabbaghizadeh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.